First Choice Neurology

Clinical Trial

Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline

A late-stage clinical trial was conducted by Biogen and Eisai and the new Alzheimer’s drug they are developing for Alzheimer’s disease slowed the rate of cognitive decline. New Alzheimer’s Drug – Lecanemab The results were strong, and this could offer hope for a new Alzheimer’s drug. The results were strong for the new medication, lecanemab. …

Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline Read More »

Early Intervention Provides Hope to Children Diagnosed with Epilepsy

Article was written by South Florida Hospital News and Healthcare Report Adam and Monica Adache knew something wasn’t right when their daughter, Maya, had a seizure at only six months old. When those seizures continued to happen, they became extremely concerned. During one episode, she also had a high fever and her pediatrician recommended she …

Early Intervention Provides Hope to Children Diagnosed with Epilepsy Read More »

BAN2401 Phase 3 Clinical Trial Starting April 2019

We are enthusiastic about the results of the BAN2401 phase 2 clinical trial for dementia. The study assessed changes from baseline to 18 months in biomarkers measuring the underlying disease pathophysiology, including changes in amyloid accumulated in the brain as measured by amyloid PET (positron emission tomography). The clinical endpoints of Alzheimer’s Disease Composite Score …

BAN2401 Phase 3 Clinical Trial Starting April 2019 Read More »

Translate »